Christina Bjerre

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

Andreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Bjerre et al. · Nature Medicine · 2022 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

Christina Bjerre, Lena Vinther, Kirstine Belling et al. · Tumor Biology · 2013 · 19 citations

Medicine, Endocrinology, Oncology +16

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

Sanne Løkkegaard, Daniel Eliáš, Carla L. Alves et al. · npj Breast Cancer · 2021 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +16

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

Christina Bjerre, Ann Knoop, Karsten Bjerre et al. · Acta Oncologica · 2012 · 15 citations · Full text

Medicine, Endocrinology, Oncology +17

Absence of triazirine intermediates in the photolytic formation of azides from mesoionic 3-substituted 1,2,3,4-oxatriazolylio-5-oxides

Christina Bjerre, C. Christophersen, Niels Harrit et al. · Tetrahedron · 1979 · 10 citations

Natural Sciences, Chemistry, Inorganic Chemistry +6